In the study of uncommon congenital disorders, collaboration is key to potential new insights and discoveries. The Gabriella Miller Kids First Pediatric Research Program Data Resource Center announced in September the public release of three comprehensive datasets related to childhood cancers and congenital disorders, one of which was provided by The University of Texas Health […]
Share This Story
Charles P. France, PhD, to lead methocinnamox drug development program The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was awarded a $12 million cooperative agreement (U01) from the National Institutes of Health’s National Institute on Drug Abuse to further develop methocinnamox (MCAM) as a treatment for opioid use disorder. […]
Share This Story
Pancreatic ductal adenocarcinoma (PDAC), a certain type of pancreatic cancer, is a ruthless killer with an average five-year survival rate of less than 10%. Most patients are diagnosed at a late stage when the cancer has already spread throughout their bodies. And the problem is only growing worse. By 2030, pancreatic cancer is expected to […]
Share This Story
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was recently awarded a $12.6 million program project grant (P01) from the National Institutes of Health’s National Cancer Institute to expand collaborative efforts to explore the biological mechanisms of BRCA1, BRCA2 and related tumor suppressors and to shed light on potential […]
Share This Story
Content by Claire Kowalick The University of Texas Health Science Center at San Antonio (UT Health San Antonio) received a collaborative $12.6 million program project grant from the National Cancer Institute to define the functions and regulation of BRCA1, BRCA2 and related tumor suppressor genes and find new ways to combat cancer. The $12.6 million grant […]
Share This Story
In landmark research, scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have reported the largest-ever genome-wide association study of dementia from all causes, revealing an overlap of genetic risks including neurodegeneration, vascular factors and cerebral small-vessel disease. Genome-wide association studies help scientists identify genes associated with […]
Share This Story
Ronald Rodriguez, MD, PhD, professor of medical education and urology at Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) discovers the combination of valproic acid and docosahexaenoic acid (DHA) may reduce the risk of contracting COVID-19 and lessen its severity, according to […]
Share This Story
For the past decade, adolescent mental health disorders have skyrocketed, an issue propelled even further by the COVID-19 pandemic. Mental health has declined surreptitiously for millions of people in recent years, affecting even the youngest among us. According to the American Academy of Child Psychiatry (AACAP), each year about one in six children aged 6-17 […]
Share This Story
A team of researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) are among four teams from across the United States that have been selected to launch community engagement centers thanks to a generous contribution from the American Heart Association and the Robert Wood Johnson Foundation. A total gift of $20 million […]
Share This Story
UT Health San Antonio urologist demonstrates potential of valproic acid-DHA in lessening risk of contracting COVID-19 When the world locked down due to the COVID-19 pandemic in 2020, rather than slowing down, this distinguished urologist and medical educator merely switched gears. Ronald Rodriguez, MD, PhD, is a professor of medical education and urology at Joe […]
Share This Story